1. Home
  2. BLTE vs SPT Comparison

BLTE vs SPT Comparison

Compare BLTE & SPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLTE
  • SPT
  • Stock Information
  • Founded
  • BLTE 2018
  • SPT 2010
  • Country
  • BLTE United States
  • SPT United States
  • Employees
  • BLTE N/A
  • SPT N/A
  • Industry
  • BLTE Biotechnology: Pharmaceutical Preparations
  • SPT Computer Software: Prepackaged Software
  • Sector
  • BLTE Health Care
  • SPT Technology
  • Exchange
  • BLTE Nasdaq
  • SPT Nasdaq
  • Market Cap
  • BLTE 2.1B
  • SPT 1.8B
  • IPO Year
  • BLTE 2022
  • SPT 2019
  • Fundamental
  • Price
  • BLTE $64.12
  • SPT $32.45
  • Analyst Decision
  • BLTE Strong Buy
  • SPT Buy
  • Analyst Count
  • BLTE 4
  • SPT 15
  • Target Price
  • BLTE $89.00
  • SPT $46.92
  • AVG Volume (30 Days)
  • BLTE 62.6K
  • SPT 591.9K
  • Earning Date
  • BLTE 11-12-2024
  • SPT 02-18-2025
  • Dividend Yield
  • BLTE N/A
  • SPT N/A
  • EPS Growth
  • BLTE N/A
  • SPT N/A
  • EPS
  • BLTE N/A
  • SPT N/A
  • Revenue
  • BLTE N/A
  • SPT $392,402,000.00
  • Revenue This Year
  • BLTE N/A
  • SPT $22.78
  • Revenue Next Year
  • BLTE N/A
  • SPT $14.58
  • P/E Ratio
  • BLTE N/A
  • SPT N/A
  • Revenue Growth
  • BLTE N/A
  • SPT 26.70
  • 52 Week Low
  • BLTE $31.01
  • SPT $25.05
  • 52 Week High
  • BLTE $86.53
  • SPT $68.41
  • Technical
  • Relative Strength Index (RSI)
  • BLTE 44.50
  • SPT 51.29
  • Support Level
  • BLTE $60.00
  • SPT $33.62
  • Resistance Level
  • BLTE $76.87
  • SPT $36.30
  • Average True Range (ATR)
  • BLTE 4.51
  • SPT 1.87
  • MACD
  • BLTE -0.44
  • SPT -0.21
  • Stochastic Oscillator
  • BLTE 24.42
  • SPT 33.39

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

About SPT Sprout Social Inc

Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. The firm generates majority revenue from software subscriptions.

Share on Social Networks: